HRC Fertility Launches Innovative Clinical Trial With Gameto for More Approachable IVF
HRC Fertility Launches Innovative Clinical Trial With Gameto for More Approachable IVF
HRC Fertility is proud to announce its participation in a groundbreaking clinical trial evaluating Fertilo, an investigational approach to in vitro maturation (IVM) developed by biotechology innovator Gameto. Fertilo aims to notably reduce the physical, emotional, and financial burden of traditional IVF and egg freezing by maturing eggs outside the body using lab ovarian support cells. This study will compare Fertilo to current in vitro maturation methods, focusing on outcomes like egg quality and pregnancy rates.
HRC Fertility is currently screening participants for the GAM-01 Study to further research this clinical trial protocol and outcomes. The trial is led by Dr. Robert Boostanfar of HRC Fertility's Valley Region, and includes Dr. Alison Peck, Dr. David Tourgeman, and Dr. Irene Woo.
Participant Criteria Includes:
HRC Fertility is proud to announce its participation in a groundbreaking clinical trial evaluating Fertilo, an investigational approach to in vitro maturation (IVM) developed by biotechology innovator Gameto. Fertilo aims to notably reduce the physical, emotional, and financial burden of traditional IVF and egg freezing by maturing eggs outside the body using lab ovarian support cells. This study will compare Fertilo to current in vitro maturation methods, focusing on outcomes like egg quality and pregnancy rates.
HRC Fertility is currently screening participants for the GAM-01 Study to further research this clinical trial protocol and outcomes. The trial is led by Dr. Robert Boostanfar of HRC Fertility's Valley Region, and includes Dr. Alison Peck, Dr. David Tourgeman, and Dr. Irene Woo.
Participant Criteria Includes:
- Ages 18-35
- Anti-Mullerian Hormone (AMH) > 3ng/mL
- Body Mass Index (BMI) 21-40
- Undergoing Assisted Reproductive Treatment
- Normal Uterine Cavity
- No endometriosis or presence of endometrioma
- Male partner with adequate semen analysis
About Gameto
Gameto is a biotechnology company redefining women's healthcare through cellular engineering. Focused on solving major challenges in reproductive health, Gameto develops therapies that aim to modernize fertility care, ovarian aging, and menopause. It's lead technology, Fertilo, uses lab-grown ovarian support cells to reduce the physical, emotional, and financial strain of traditional IVF and egg freezing.
Gameto's mission is to bring safer, faster, and more accessible fertility solutions to women everywhere.
HRC Fertility
-
Monica Ibanez Marketing Coordinator
- July 29, 2025
- (818) 788-7288
- Send Email
